New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country.
from Health https://ift.tt/2twfjFv
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment